{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:13:19Z","timestamp":1790899999308,"version":"4.1.0"},"reference-count":372,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:00:00Z","timestamp":1759622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:00:00Z","timestamp":1759622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug Development Research"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Cancer remains a significant global health challenge, with increasing incidence and mortality rates worldwide. The mechanistic target of rapamycin (mTOR) pathway, a central regulator of cell growth, proliferation, metabolism, and survival, has emerged as a promising therapeutic target in cancer. Dysregulation of mTOR signaling is implicated in various cancers, including breast, colon, lung, renal cell carcinoma, and multiple myeloma, making it an attractive target for inhibition. This review provides a comprehensive analysis of mTOR\u2010targeted therapies, focusing on the clinical outcomes, efficacy, safety, and adverse effects of mTOR inhibitors. We explore the mechanisms of mTOR regulation, the impact of mTOR mutations on drug sensitivity, and the development of resistance to mTOR inhibitors. The review also highlights the potential of combination therapies and next\u2010generation inhibitors to overcome resistance and improve therapeutic outcomes. Key mTOR inhibitors, including rapalogs (e.g., sirolimus, everolimus) and ATP\u2010competitive inhibitors (e.g., MLN0128, PP242), are discussed in detail, along with their clinical applications and limitations. Additionally, we summarize the findings from major clinical trials, including FDA\u2010approved mTOR inhibitors like everolimus and temsirolimus, and non\u2010FDA\u2010approved inhibitors such as sapanisertib and ridaforolimus. The review underscores the importance of understanding mTOR signaling and its role in cancer progression, offering insights into the future of mTOR\u2010targeted therapies in oncology.<\/jats:p>","DOI":"10.1002\/ddr.70167","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:00:18Z","timestamp":1759687218000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Targeting mTOR Kinase for Cancer Treatment: A Comprehensive Review With Clinical Insights"],"prefix":"10.1002","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5848-1245","authenticated-orcid":false,"given":"Md. Takdir","family":"Hossain","sequence":"first","affiliation":[{"name":"Department of Pharmacy Bangabandhu Sheikh Mujibur Rahman Science and Technology University Gopalganj Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8334-6374","authenticated-orcid":false,"given":"Md. Arafat","family":"Hossain","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Bangabandhu Sheikh Mujibur Rahman Science and Technology University Gopalganj Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,10,5]]},"reference":[{"key":"e_1_2_16_2_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4548"},{"key":"e_1_2_16_3_1","doi-asserted-by":"publisher","DOI":"10.1534\/genetics.118.301296"},{"key":"e_1_2_16_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02706-8"},{"key":"e_1_2_16_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70138-X"},{"key":"e_1_2_16_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70062-6"},{"key":"e_1_2_16_7_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.248"},{"key":"e_1_2_16_8_1","doi-asserted-by":"crossref","unstructured":"Armstrong A. J. S.Broderick T.Eisen et al.2015. \u201cFinal Clinical Results of a Randomized Phase Ii International Trial of Everolimus vs. Sunitinib in Patients With Metastatic Non\u2010Clear Cell Renal Cell Carcinoma (ASPEN).\u201d","DOI":"10.1200\/jco.2015.33.15_suppl.4507"},{"key":"e_1_2_16_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00515-X"},{"key":"e_1_2_16_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12405"},{"key":"e_1_2_16_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.0708"},{"key":"e_1_2_16_12_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25430"},{"key":"e_1_2_16_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0621-5"},{"key":"e_1_2_16_14_1","doi-asserted-by":"publisher","DOI":"10.2174\/156800908786733513"},{"key":"e_1_2_16_15_1","doi-asserted-by":"crossref","unstructured":"Bareti\u0107 D. andR. L.Williams.2014. \u201cThe Structural Basis for mTOR Function.\u201d In Seminars in Cell & Developmental Biology (Vol. 36 pp. 91\u2010101). Academic Press.","DOI":"10.1016\/j.semcdb.2014.09.024"},{"key":"e_1_2_16_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1232044"},{"key":"e_1_2_16_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109653"},{"key":"e_1_2_16_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.8391"},{"key":"e_1_2_16_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2422"},{"issue":"9","key":"e_1_2_16_20_1","first-page":"1210","article-title":"Decreased Affinity for Efflux Transporters Increases Brain Penetrance and Molecular Targeting of a PI3K\/mTOR Inhibitor in a Mouse Model of Glioblastoma","volume":"17","author":"Becker C. M.","year":"2015","journal-title":"Neuro\u2010Oncology"},{"key":"e_1_2_16_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112362"},{"key":"e_1_2_16_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn066"},{"key":"e_1_2_16_23_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2005516"},{"key":"e_1_2_16_24_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1769"},{"key":"e_1_2_16_25_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1228792"},{"key":"e_1_2_16_26_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0489"},{"key":"e_1_2_16_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1640-T"},{"key":"e_1_2_16_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-015-3615-9"},{"key":"e_1_2_16_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv166"},{"key":"e_1_2_16_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2133"},{"key":"e_1_2_16_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202100332"},{"key":"e_1_2_16_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0004(00)01563-2"},{"key":"e_1_2_16_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/369756a0"},{"key":"e_1_2_16_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30030-9"},{"key":"e_1_2_16_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-017-3343-4"},{"key":"e_1_2_16_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.11.027"},{"key":"e_1_2_16_37_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005090993"},{"key":"e_1_2_16_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149388"},{"key":"e_1_2_16_39_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02871-18"},{"key":"e_1_2_16_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.247"},{"key":"e_1_2_16_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2008.07.078"},{"key":"e_1_2_16_42_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.159046"},{"key":"e_1_2_16_43_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aag1417"},{"key":"e_1_2_16_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.2170"},{"key":"e_1_2_16_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30125-5"},{"key":"e_1_2_16_46_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-1204"},{"key":"e_1_2_16_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602162"},{"key":"e_1_2_16_48_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.66.130"},{"key":"e_1_2_16_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.09.014"},{"key":"e_1_2_16_50_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.29.15_suppl.10005"},{"key":"e_1_2_16_51_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.6329"},{"key":"e_1_2_16_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112820"},{"key":"e_1_2_16_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature13264"},{"key":"e_1_2_16_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox209"},{"key":"e_1_2_16_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21953"},{"key":"e_1_2_16_56_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.322339.118"},{"key":"e_1_2_16_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3394-2"},{"key":"e_1_2_16_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30107-3"},{"key":"e_1_2_16_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac192"},{"key":"e_1_2_16_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29927"},{"key":"e_1_2_16_61_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1751"},{"key":"e_1_2_16_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-018-3543-6"},{"key":"e_1_2_16_63_1","doi-asserted-by":"publisher","DOI":"10.2174\/156800910791517172"},{"key":"e_1_2_16_64_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1402"},{"key":"e_1_2_16_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.59"},{"key":"e_1_2_16_66_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.137588"},{"key":"e_1_2_16_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1819"},{"key":"e_1_2_16_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-02025-9"},{"key":"e_1_2_16_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.233"},{"key":"e_1_2_16_70_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8383"},{"key":"e_1_2_16_71_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25869"},{"key":"e_1_2_16_72_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao1583"},{"key":"e_1_2_16_73_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0035"},{"key":"e_1_2_16_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2016.04.019"},{"key":"e_1_2_16_75_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.5766"},{"key":"e_1_2_16_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-018-0120-9"},{"key":"e_1_2_16_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2015.03.033"},{"key":"e_1_2_16_78_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0940"},{"key":"e_1_2_16_79_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37539"},{"key":"e_1_2_16_80_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00735-09"},{"key":"e_1_2_16_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-018-0081-9"},{"key":"e_1_2_16_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.92"},{"key":"e_1_2_16_83_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201610060"},{"key":"e_1_2_16_84_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.3033"},{"key":"e_1_2_16_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.08.033"},{"key":"e_1_2_16_86_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1204166"},{"key":"e_1_2_16_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.01.014"},{"key":"e_1_2_16_88_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1108"},{"key":"e_1_2_16_89_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000038"},{"key":"e_1_2_16_90_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.0735"},{"key":"e_1_2_16_91_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1135"},{"key":"e_1_2_16_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.102886"},{"key":"e_1_2_16_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2013.02.003"},{"key":"e_1_2_16_94_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0694-1"},{"key":"e_1_2_16_95_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.1310"},{"key":"e_1_2_16_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12844"},{"key":"e_1_2_16_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.03.084"},{"key":"e_1_2_16_98_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-18-0510"},{"key":"e_1_2_16_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.242"},{"key":"e_1_2_16_100_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.23.622"},{"key":"e_1_2_16_101_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7648"},{"key":"e_1_2_16_102_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS20-PD1-01"},{"key":"e_1_2_16_103_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-2652"},{"key":"e_1_2_16_104_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000965"},{"key":"e_1_2_16_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-012-2298-8"},{"key":"e_1_2_16_106_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu124"},{"key":"e_1_2_16_107_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.1630"},{"key":"e_1_2_16_108_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3166"},{"key":"e_1_2_16_109_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0929"},{"key":"e_1_2_16_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71136-2"},{"key":"e_1_2_16_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-440X(99)80052-9"},{"key":"e_1_2_16_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2007.05.008"},{"key":"e_1_2_16_113_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-15-0365"},{"key":"e_1_2_16_114_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.25288"},{"key":"e_1_2_16_115_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-220889"},{"key":"e_1_2_16_116_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0180"},{"key":"e_1_2_16_117_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-010-9235-2"},{"key":"e_1_2_16_118_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1098"},{"key":"e_1_2_16_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2023.09.013"},{"key":"e_1_2_16_120_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-2076"},{"key":"e_1_2_16_121_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2337"},{"key":"e_1_2_16_122_1","doi-asserted-by":"crossref","unstructured":"Hasskarl J.2018. \u201cEverolimus. Small Molecules in Oncology \u201d 101\u2013123.","DOI":"10.1007\/978-3-319-91442-8_8"},{"key":"e_1_2_16_123_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2136"},{"key":"e_1_2_16_124_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0118"},{"key":"e_1_2_16_125_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.2082"},{"key":"e_1_2_16_126_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.6376"},{"key":"e_1_2_16_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.10.029"},{"key":"e_1_2_16_128_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0754-1"},{"key":"e_1_2_16_129_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066838"},{"key":"e_1_2_16_130_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.20.7004-7014.2002"},{"key":"e_1_2_16_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.11.099"},{"key":"e_1_2_16_132_1","doi-asserted-by":"crossref","unstructured":"Hurvitz S. A. F.Andre M.Cristofanilli et al.2023. \u201cA Phase 3 Study of Gedatolisib Plus Fulvestrant With and Without Palbociclib in Patients With HR+\/HER2\u2010Advanced Breast Cancer Previously Treated With a CDK4\/6 Inhibitor Plus a Nonsteroidal Aromatase Inhibitor (VIKTORIA\u20101).\u201d","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS1118"},{"key":"e_1_2_16_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00051-0"},{"key":"e_1_2_16_134_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-015-3282-x"},{"key":"e_1_2_16_135_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.3961"},{"key":"e_1_2_16_136_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb839"},{"key":"e_1_2_16_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.06.055"},{"key":"e_1_2_16_138_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-1726"},{"key":"e_1_2_16_139_1","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2020.1063"},{"key":"e_1_2_16_140_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.2262"},{"key":"e_1_2_16_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2015.05.010"},{"key":"e_1_2_16_142_1","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3604"},{"key":"e_1_2_16_143_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00601-09"},{"key":"e_1_2_16_144_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not139"},{"key":"e_1_2_16_145_1","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2010.82"},{"key":"e_1_2_16_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.07.017"},{"key":"e_1_2_16_147_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aau8544"},{"key":"e_1_2_16_148_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-026344"},{"key":"e_1_2_16_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62127-9"},{"key":"e_1_2_16_150_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1310434110"},{"key":"e_1_2_16_151_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw669"},{"key":"e_1_2_16_152_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g6679"},{"issue":"3","key":"e_1_2_16_153_1","first-page":"477","article-title":"Suppression of Phosphatidylinositol 3\u2010Kinase\/Akt Signaling Pathway Is a Determinant of the Sensitivity to a Novel Histone Deacetylase Inhibitor, FK228, in Lung Adenocarcinoma Cells","volume":"13","author":"Kodani M.","year":"2005","journal-title":"Oncology Reports"},{"key":"e_1_2_16_154_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw054"},{"key":"e_1_2_16_155_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1223"},{"key":"e_1_2_16_156_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-18-0260"},{"key":"e_1_2_16_157_1","doi-asserted-by":"crossref","unstructured":"Kulke M. H. D.Niedzwiecki N. R.Foster et al.2015. \u201cRandomized PHASE II STUdy of Everolimus (E) Versus Everolimus Plus Bevacizumab (E+ B) in Patients (Pts) With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors (pNET) CALGB 80701 (Alliance).\u201d","DOI":"10.1200\/jco.2015.33.15_suppl.4005"},{"key":"e_1_2_16_158_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2631"},{"key":"e_1_2_16_159_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2009-0178"},{"key":"e_1_2_16_160_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.1291"},{"key":"e_1_2_16_161_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.051011"},{"key":"e_1_2_16_162_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12912"},{"key":"e_1_2_16_163_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2465"},{"key":"e_1_2_16_164_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-3279"},{"key":"e_1_2_16_165_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.22441"},{"key":"e_1_2_16_166_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4131"},{"key":"e_1_2_16_167_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1276"},{"key":"e_1_2_16_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2013.06.020"},{"key":"e_1_2_16_169_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01800-7"},{"key":"e_1_2_16_170_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4598-1"},{"key":"e_1_2_16_171_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0460"},{"key":"e_1_2_16_172_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2860"},{"key":"e_1_2_16_173_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13273-021-00131-y"},{"key":"e_1_2_16_174_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2007.11.003"},{"key":"e_1_2_16_175_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou328"},{"key":"e_1_2_16_176_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121584"},{"key":"e_1_2_16_177_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1385"},{"key":"e_1_2_16_178_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2109"},{"key":"e_1_2_16_179_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1162981"},{"key":"e_1_2_16_180_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2488"},{"key":"e_1_2_16_181_1","doi-asserted-by":"publisher","DOI":"10.1038\/35106079"},{"key":"e_1_2_16_182_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.59"},{"key":"e_1_2_16_183_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2004.00188.x"},{"key":"e_1_2_16_184_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0134"},{"key":"e_1_2_16_185_1","doi-asserted-by":"publisher","DOI":"10.1200\/PO.21.00448"},{"key":"e_1_2_16_186_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-017-0467-7"},{"key":"e_1_2_16_187_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2010.06.029"},{"key":"e_1_2_16_188_1","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2015.68"},{"key":"e_1_2_16_189_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.772988"},{"key":"e_1_2_16_190_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2123"},{"key":"e_1_2_16_191_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2004.02.051"},{"key":"e_1_2_16_192_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-013-2250-6"},{"key":"e_1_2_16_193_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-018-0380-x"},{"key":"e_1_2_16_194_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010173"},{"key":"e_1_2_16_195_1","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.2013.827397"},{"key":"e_1_2_16_196_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.365"},{"key":"e_1_2_16_197_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.0345"},{"key":"e_1_2_16_198_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds602"},{"key":"e_1_2_16_199_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02701-2"},{"key":"e_1_2_16_200_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-3377"},{"key":"e_1_2_16_201_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-013-2339-y"},{"key":"e_1_2_16_202_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.07.015"},{"key":"e_1_2_16_203_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.003991"},{"key":"e_1_2_16_204_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.04.002"},{"key":"e_1_2_16_205_1","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2017-000291"},{"issue":"2","key":"e_1_2_16_206_1","first-page":"322","article-title":"Phase II Study of Sapanisertib (TAK\u2010228) in Women With Recurrent or Metastatic Endometrial Cancer","volume":"157","author":"Moore K. N.","year":"2020","journal-title":"Gynecologic Oncology"},{"key":"e_1_2_16_207_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2017.08.013"},{"key":"e_1_2_16_208_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.08.010"},{"key":"e_1_2_16_209_1","doi-asserted-by":"crossref","unstructured":"Motzer R. J. C. H.Barrios T. M.Kim et al.2013. \u201cRecord\u20103: Phase II Randomized Trial Comparing Sequential First\u2010Line Everolimus (EVE) and Second\u2010Line Sunitinib (SUN) Versus First\u2010Line SUN and Second\u2010Line EVE in Patients With Metastatic Renal Cell Carcinoma (mRCC).\u201d","DOI":"10.1200\/jco.2013.31.15_suppl.4504"},{"key":"e_1_2_16_210_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.6911"},{"key":"e_1_2_16_211_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33033"},{"key":"e_1_2_16_212_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61039-9"},{"key":"e_1_2_16_213_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25219"},{"key":"e_1_2_16_214_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.5916"},{"key":"e_1_2_16_215_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00290-9"},{"key":"e_1_2_16_216_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0787-5"},{"key":"e_1_2_16_217_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-15-0926"},{"key":"e_1_2_16_218_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.368"},{"key":"e_1_2_16_219_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2979"},{"key":"e_1_2_16_220_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0061"},{"key":"e_1_2_16_221_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.46"},{"key":"e_1_2_16_222_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-3516"},{"key":"e_1_2_16_223_1","unstructured":"National Cancer Institute. \u201cUSA. What Is Cancer?\u201dhttps:\/\/www.cancer.gov\/about-cancer\/understanding\/what-is-cancer. (accessed December 19 2023)."},{"key":"e_1_2_16_224_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2013.02.005"},{"key":"e_1_2_16_225_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M801546200"},{"key":"e_1_2_16_226_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.3552"},{"key":"e_1_2_16_227_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0803"},{"key":"e_1_2_16_228_1","doi-asserted-by":"crossref","unstructured":"O'Regan R. M.Ozguroglu F.Andre et al.2013. \u201cPhase III Randomized Double\u2010Blind Placebo\u2010Controlled Multicenter Trial of Daily Everolimus Plus Weekly Trastuzumab and Vinorelbine in Trastuzumab\u2010Resistant Advanced Breast Cancer (BOLERO\u20103).\u201d","DOI":"10.1200\/jco.2013.31.15_suppl.505"},{"key":"e_1_2_16_229_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2925"},{"key":"e_1_2_16_230_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.34.1578"},{"key":"e_1_2_16_231_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.8871"},{"key":"e_1_2_16_232_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2010.520701"},{"key":"e_1_2_16_233_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2013.752814"},{"key":"e_1_2_16_234_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318155a439"},{"key":"e_1_2_16_235_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01608-z"},{"key":"e_1_2_16_236_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.974040"},{"key":"e_1_2_16_237_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-010-0500-z"},{"key":"e_1_2_16_238_1","doi-asserted-by":"crossref","unstructured":"Park S. J.Shim H. A.Jung et al.2019. \u201cBiomarker\u2010Driven Phase II Umbrella Trial Study of AZD1775 AZD2014 AZD2811 Monotherapy in Relapsed Small Cell Lung Cancer.\u201d","DOI":"10.1200\/JCO.2019.37.15_suppl.8514"},{"key":"e_1_2_16_239_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31662"},{"key":"e_1_2_16_240_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.10.019"},{"key":"e_1_2_16_241_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.808"},{"key":"e_1_2_16_242_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx193"},{"key":"e_1_2_16_243_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61742-X"},{"key":"e_1_2_16_244_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30471-0"},{"key":"e_1_2_16_245_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2669-3"},{"key":"e_1_2_16_246_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.08.038"},{"key":"e_1_2_16_247_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature21378"},{"key":"e_1_2_16_248_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0842"},{"issue":"4","key":"e_1_2_16_249_1","first-page":"1","article-title":"Sirolimus: A Therapeutic Advance for Dermatologic Disease","volume":"19","author":"Peters T.","year":"2014","journal-title":"Skin Therapy Letter"},{"key":"e_1_2_16_250_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602902"},{"key":"e_1_2_16_251_1","first-page":"R11","article-title":"mTOR Signaling: Implications for Cancer and Anticancer Therapy","volume":"96","author":"Petroulakis E.","year":"2007","journal-title":"British Journal of Cancer"},{"key":"e_1_2_16_252_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.09.017"},{"key":"e_1_2_16_253_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.06.115"},{"key":"e_1_2_16_254_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.01.019"},{"key":"e_1_2_16_255_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041743"},{"key":"e_1_2_16_256_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms13021886"},{"key":"e_1_2_16_257_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb840"},{"key":"e_1_2_16_258_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.08.035"},{"key":"e_1_2_16_259_1","doi-asserted-by":"crossref","unstructured":"Powles T. M. J.Wheater O.Din et al.2015. \u201cA Randomized Phase II Study of AZ2014 Versus Everolimus in Patients With VEGF Refractory Metastatic Clear Cell Renal Cancer (mRCC).\u201d","DOI":"10.1200\/jco.2015.33.7_suppl.409"},{"key":"e_1_2_16_260_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-534297"},{"key":"e_1_2_16_261_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00428-5"},{"key":"e_1_2_16_262_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-022-01311-w"},{"key":"e_1_2_16_263_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-020-00770-6"},{"key":"e_1_2_16_264_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2017.11.027"},{"key":"e_1_2_16_265_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.11.022"},{"key":"e_1_2_16_266_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-009-9950-0"},{"key":"e_1_2_16_267_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2215"},{"key":"e_1_2_16_268_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)84075-9"},{"key":"e_1_2_16_269_1","doi-asserted-by":"crossref","unstructured":"Riely G. J. J. R.Brahmer D.Planchard et al.2012. \u201cA Randomized Discontinuation Phase II Trial of Ridaforolimus in Non\u2010Small Cell Lung Cancer (NSCLC) Patients With KRAS Mutations.\u201d","DOI":"10.1200\/jco.2012.30.15_suppl.7531"},{"key":"e_1_2_16_270_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.5305"},{"key":"e_1_2_16_271_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-10-0792"},{"key":"e_1_2_16_272_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1228771"},{"key":"e_1_2_16_273_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature17963"},{"key":"e_1_2_16_274_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.03.006"},{"key":"e_1_2_16_275_1","doi-asserted-by":"crossref","unstructured":"Rubio\u2010Viqueira B. andM.Hidalgo.2006. \u201cTargeting mTOR for Cancer Treatment.\u201d New Trends in Cancer for the 21st Century 309\u2010327.","DOI":"10.1007\/978-1-4020-5133-3_24"},{"key":"e_1_2_16_276_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv595"},{"key":"e_1_2_16_277_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-017-4375-5"},{"key":"e_1_2_16_278_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.02.024"},{"key":"e_1_2_16_279_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-009-0107-z"},{"key":"e_1_2_16_280_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.28"},{"key":"e_1_2_16_281_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.004"},{"key":"e_1_2_16_282_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0800939105"},{"key":"e_1_2_16_283_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.2526"},{"issue":"2","key":"e_1_2_16_284_1","first-page":"698","article-title":"Everolimus in Patients With Advanced Follicular\u2010Derived Thyroid Cancer: Results of a Phase II Clinical Trial","volume":"102","author":"Schneider T. C.","year":"2017","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_16_285_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0322-4"},{"key":"e_1_2_16_286_1","doi-asserted-by":"crossref","unstructured":"Sehgal S. N.2003. \u201cSirolimus: Its Discovery Biological Properties and Mechanism of Action.\u201d In Transplantation Proceedings (Vol. 35 No. 3 pp. S7\u2010S14). Elsevier.","DOI":"10.1016\/S0041-1345(03)00211-2"},{"key":"e_1_2_16_287_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2014.07.008"},{"key":"e_1_2_16_288_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-011-1788-4"},{"key":"e_1_2_16_289_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp504"},{"key":"e_1_2_16_290_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1306"},{"key":"e_1_2_16_291_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2018.04.011"},{"key":"e_1_2_16_292_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.09.006"},{"key":"e_1_2_16_293_1","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2017.181"},{"key":"e_1_2_16_294_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12132"},{"key":"e_1_2_16_295_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-021-00855-w"},{"key":"e_1_2_16_296_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2381"},{"key":"e_1_2_16_297_1","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2015.146"},{"key":"e_1_2_16_298_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.113"},{"key":"e_1_2_16_299_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1505787112"},{"key":"e_1_2_16_300_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763"},{"key":"e_1_2_16_301_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-14-0711"},{"key":"e_1_2_16_302_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.2813"},{"key":"e_1_2_16_303_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.006029"},{"key":"e_1_2_16_304_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0284"},{"key":"e_1_2_16_305_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.07.005"},{"key":"e_1_2_16_306_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12958"},{"key":"e_1_2_16_307_1","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-22-0260"},{"key":"e_1_2_16_308_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0917"},{"key":"e_1_2_16_309_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hys110"},{"key":"e_1_2_16_310_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_2_16_311_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102373"},{"key":"e_1_2_16_312_1","doi-asserted-by":"crossref","unstructured":"Tabernero J. N.Brega C.Davis et al.2014. \u201cA Randomized Phase II Study (B2151005) of the Intravenous Phosphatidylinositol 3\u2010kinase (PI3K)\/Mammalian Target of Rapamycin (mTOR) Inhibitor PF\u201005212384 Plus Irinotecan Versus Cetuximab Plus Irinotecan in Patients With Wild\u2010Type KRAS Metastatic Colorectal Cancer (mCRC).\u201d","DOI":"10.1200\/jco.2014.32.15_suppl.tps3649"},{"key":"e_1_2_16_313_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0595"},{"key":"e_1_2_16_314_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78239"},{"key":"e_1_2_16_315_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1759"},{"key":"e_1_2_16_316_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0802"},{"key":"e_1_2_16_317_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2021.100655"},{"key":"e_1_2_16_318_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(03)00506-2"},{"key":"e_1_2_16_319_1","doi-asserted-by":"publisher","DOI":"10.2741\/4867"},{"key":"e_1_2_16_320_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M900301200"},{"key":"e_1_2_16_321_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030755"},{"key":"e_1_2_16_322_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.86"},{"key":"e_1_2_16_323_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.06.033"},{"key":"e_1_2_16_324_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0608510104"},{"key":"e_1_2_16_325_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2002165"},{"key":"e_1_2_16_326_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2015.08.008"},{"key":"e_1_2_16_327_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3237"},{"key":"e_1_2_16_328_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11205"},{"key":"e_1_2_16_329_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2016.1132698"},{"key":"e_1_2_16_330_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0582-9"},{"key":"e_1_2_16_331_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi113"},{"key":"e_1_2_16_332_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01041-x"},{"key":"e_1_2_16_333_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-017-0530-5"},{"key":"e_1_2_16_334_1","doi-asserted-by":"crossref","unstructured":"Wainberg Z. A. N.Brega C.Davis et al.2014. \u201cRandomized Phase Ib\/II Study of PF\u201005212384 Plus 5\u2010Fluorouracil\u2010Leucovorin\u2010Irinotecan (FOLFIRI) Versus Bevacizumab Plus FOLFIRI in Metastatic Colorectal Cancer (B2151007; NCT01937715).\u201d","DOI":"10.1200\/jco.2014.32.15_suppl.tps3657"},{"key":"e_1_2_16_335_1","doi-asserted-by":"publisher","DOI":"10.1593\/neo.05820"},{"key":"e_1_2_16_336_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature22344"},{"key":"e_1_2_16_337_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02243-3"},{"key":"e_1_2_16_338_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139237"},{"key":"e_1_2_16_339_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1257132"},{"key":"e_1_2_16_340_1","doi-asserted-by":"crossref","unstructured":"Wang X. P.Yue C. B.Chan et al.2007. \u201cInhibition of Mammalian Target of Rapamycin Induces Phosphatidylinositol 3\u2010kinase\u2010Dependent and Mnk\u2010Mediated Eukaryotic Translation Initiation Factor 4E Phosphorylation.\u201d Molecular and Cellular Biology.","DOI":"10.1128\/MCB.00760-07"},{"key":"e_1_2_16_341_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4765"},{"key":"e_1_2_16_342_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou235"},{"key":"e_1_2_16_343_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov083"},{"key":"e_1_2_16_344_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8497"},{"key":"e_1_2_16_345_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2013-0355"},{"key":"e_1_2_16_346_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.3331"},{"key":"e_1_2_16_347_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aab2674"},{"key":"e_1_2_16_348_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature21423"},{"key":"e_1_2_16_349_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221994"},{"key":"e_1_2_16_350_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23022"},{"key":"e_1_2_16_351_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.7b00277"},{"key":"e_1_2_16_352_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.302117"},{"key":"e_1_2_16_353_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.03.143"},{"key":"e_1_2_16_354_1","first-page":"8","article-title":"Sirolimus: A Current Perspective","volume":"1","author":"Yakupo\u0111lu Y. K.","year":"2003","journal-title":"Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation"},{"issue":"1","key":"e_1_2_16_355_1","first-page":"8","article-title":"Sirolimus: A Current Perspective","volume":"1","author":"Yakupoglu Y. K.","year":"2003","journal-title":"Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation"},{"key":"e_1_2_16_356_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.150"},{"key":"e_1_2_16_357_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12122"},{"key":"e_1_2_16_358_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.487"},{"key":"e_1_2_16_359_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00817-X"},{"issue":"32","key":"e_1_2_16_360_1","first-page":"3906","article-title":"Everolis for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT\u20103 Study","volume":"34","author":"Yao J. C.","year":"2016","journal-title":"Journal of ClinicalpOncology"},{"key":"e_1_2_16_361_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009290"},{"key":"e_1_2_16_362_1","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12078"},{"key":"e_1_2_16_363_1","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2015.133"},{"key":"e_1_2_16_364_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv464.01"},{"key":"e_1_2_16_365_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-010-0763-9"},{"key":"e_1_2_16_366_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2011.584871"},{"key":"e_1_2_16_367_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054918"},{"key":"e_1_2_16_368_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24261"},{"key":"e_1_2_16_369_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.11.012"},{"key":"e_1_2_16_370_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.7189"},{"key":"e_1_2_16_371_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-015-0261-3"},{"key":"e_1_2_16_372_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.014"},{"key":"e_1_2_16_373_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-020-00396-1"}],"container-title":["Drug Development Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ddr.70167","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ddr.70167","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ddr.70167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T11:52:51Z","timestamp":1771069971000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/ddr.70167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,5]]},"references-count":372,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1002\/ddr.70167"],"URL":"https:\/\/doi.org\/10.1002\/ddr.70167","archive":["Portico"],"relation":{},"ISSN":["0272-4391","1098-2299"],"issn-type":[{"value":"0272-4391","type":"print"},{"value":"1098-2299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,5]]},"assertion":[{"value":"2025-07-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70167"}}